The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian When will the FDA reclassify BPC 157 to Category 1 Octagon AI BPC 157: Experimental Peptide Creates Risk for Athletes